Castle Biosciences, Inc. · NASDAQ:CSTL
Juvenal Tobin W sold 6,578 Castle Biosciences, Inc. shares (Form 4)
Traded Oct 28, 2026 · Filed Oct 30, 2026
On Oct 28, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 6,578 Castle Biosciences, Inc. shares at an average US$36.42 for US$240K under a trading plan, leaving 38,853 shares. Filed Oct 30, 2026 (Form 4).
- Sold
- 6,578 shares
- Price
- US$36.42 average (US$35.58 to US$36.62)
- Value
- US$240K
- Holding after
- 38,853 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Common Stock | Sale | 1,237 | US$35.58 | 44,194 | Direct |
| Oct 28, 2026 | Common Stock | Sale | 5,341 | US$36.62 | 38,853 | Direct |
Source
Download original · View original at SEC
Related
- Castle Biosciences, Inc.
- Juvenal Tobin W
- Castle Biosciences, Inc. shareholders
- Form 4 · Juvenal Tobin W · Nov 13, 2026
- Form 4 · Juvenal Tobin W · Nov 12, 2026
- Form 4 · Juvenal Tobin W · Oct 28, 2026
- Form 4 · Juvenal Tobin W · Oct 14, 2026
- Form 4 · Juvenal Tobin W · Oct 1, 2026
- Form 4 · Bradbury Daniel · Nov 19, 2026
- Form 4 · Maetzold Derek J · Nov 18, 2026
- Form 4 · Maetzold Derek J · Nov 4, 2026
- Schedule 13G/A · Principal Global Investors · Oct 29, 2026
- Form 4 · Maetzold Derek J · Oct 21, 2026